Olutosin Awolude
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Olutosin Awolude has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Bibilola Damilola Oladeji
College of Medicine, university of Ibadan
5 shared publications - Kehinde M. Kuti
Infectious Disease Institute, College of Medicine, University of Ibadan, Ibadan, Nigeria
4 shared publications - Lisa M. Kuhns
Department of Pediatrics, Feinberg School of Medicine & Ann & Robert H. Lurie Children’s Hospital of Chicago, Division of Adolescent and Young Adult Medicine, Northwestern University, Chicago, IL 60611, USA
4 shared publications - Olayinka Omigbodun
College of Medicine, University of Ibadan, Ibadan, Nigeria
3 shared publications - Aima Ahonkhai
Medical Practice Evaluation Center Massachusetts General Hospital Boston Massachusetts USA
2 shared publications - Caleb Eliazer
Medical Practice Evaluation Center, Massachusetts General Hospital , Boston, MA
2 shared publications
Latest Publications
- Open Access
Sustained Viral Suppression and its association with Psychiatric Morbidity and Sleep Quality among Older Adults with Human Immunodeficiency Virus: Evidence from a Retrospective Cohort in Ibadan, Nigeria
Purpose: Older adults with HIV are at risk of psychiatric disorders and poor sleep quality, but evidence from sub-Saharan Africa is limited, particularly regarding sustained viral suppression. This study examined the prevalence of psychiatric disorders and poor sleep quality symptoms and their association with sustained viral suppression among older adults with HIV in Nigeria. Methods: A retrospective cohort study was conducted among older adults receiving care at a tertiary HIV clinic in Ibadan, Nigeria. Viral load data from 2019-2023 were abstracted from medical records to determine sustained viral load suppression, while psychiatric morbidity and sleep quality were assessed cross-sectionally in 2023. Psychiatric morbidity, including major depressive disorder, anxiety disorder, bipolar disorder and mania, was assessed using the World Mental Health Composite International Diagnostic Interview (WMH-CIDI), while sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Mixed-effects logistic regression assessed changes in viral suppression over time and associations with psychiatric morbidity and sleep quality. Results: Among 400 participants, 63.5% were female and mean age was 58.2 years (± 6.5). The 12-month prevalence of major depressive disorder was 25.8% while 17.5% had anxiety disorder, 29.3% had poor sleep quality, 3.3%, bipolar disorder, and 1.0% mania. Viral suppression improved significantly over the retrospective period. Sustained viral suppression was significantly associated with higher odds of good sleep quality (OR = 1.69, 95% CI: 1.07–2.66, p = 0.025), but not psychiatric morbidity. Conclusion: Psychiatric disorders and poor sleep quality are common among older adults with HIV in Nigeria. Sustained viral suppression was associated with better sleep quality but not psychiatric morbidity highlighting the importance of integrating mental health and sleep assessment into comprehensive HIV care for older adults.
Open AccessSustained Viral Suppression and its association with Psychiatric Morbidity and Sleep Quality among Older Adults with Human Immunodeficiency Virus: Evidence from a Retrospective Cohort in Ibadan, Nigeria
Purpose: Older adults with HIV are at risk of psychiatric disorders and poor sleep quality, but evidence from sub-Saharan Africa is limited, particularly regarding sustained viral suppression. This study examined the prevalence of psychiatric disorders and poor sleep quality symptoms and their association with sustained viral suppression among older adults with HIV in Nigeria. Methods: A retrospective cohort study was conducted among older adults receiving care at a tertiary HIV clinic in Ibadan, Nigeria. Viral load data from 2019-2023 were abstracted from medical records to determine sustained viral load suppression, while psychiatric morbidity and sleep quality were assessed cross-sectionally in 2023. Psychiatric morbidity, including major depressive disorder, anxiety disorder, bipolar disorder and mania, was assessed using the World Mental Health Composite International Diagnostic Interview (WMH-CIDI), while sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Mixed-effects logistic regression assessed changes in viral suppression over time and associations with psychiatric morbidity and sleep quality. Results: Among 400 participants, 63.5% were female and mean age was 58.2 years (± 6.5). The 12-month prevalence of major depressive disorder was 25.8% while 17.5% had anxiety disorder, 29.3% had poor sleep quality, 3.3%, bipolar disorder, and 1.0% mania. Viral suppression improved significantly over the retrospective period. Sustained viral suppression was significantly associated with higher odds of good sleep quality (OR = 1.69, 95% CI: 1.07–2.66, p = 0.025), but not psychiatric morbidity. Conclusion: Psychiatric disorders and poor sleep quality are common among older adults with HIV in Nigeria. Sustained viral suppression was associated with better sleep quality but not psychiatric morbidity highlighting the importance of integrating mental health and sleep assessment into comprehensive HIV care for older adults.
- Open Access
- 8 October 2026
- Published by Springer Nature in Research Square
The Association of Resilience with Psychiatric Morbidity, Sleep Quality and Antiretroviral Therapy Adherence among Older Adults Living with HIV in Nigeria
Advances in antiretroviral therapy (ART) have increased survival among people living with HIV, resulting in a growing population of older adults who often face persistent psychological challenges. However, limited evidence exists on how in the face of these challenges, resilience may interact with psychiatric morbidity and HIV treatment adherence in African countries. This study therefore examined resilience among older adults living with HIV in Ibadan, Nigeria and its association with psychiatric morbidity and ART adherence. In this cross-sectional study, resilience, psychiatric morbidity and HIV treatment adherence were assessed among 400 older adults aged ≥ 50 years living with HIV. Resilience, depression, anxiety and sleep quality were measured using the 25-item Wagnild and Young resilience scale, Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder 7-item scale (GAD-7) and the Pittsburgh Sleep Quality Index (PSQI) respectively. Antiretroviral medication adherence was self-reported for the prior 30-days. Associations between resilience levels, psychiatric morbidity, and medication adherence outcomes were investigated using multivariable logistic regression controlling for demographic and clinical factors. The mean age of participants was 58.2 ± 6.5 years. Low resilience was common, affecting approximately 89.7% of the cohort. The prevalence of psychiatric morbidity was 7.8% for depression, 6.0% for anxiety, and 15.2% for poor sleep quality. Overall, ART adherence was relatively high, with 85.5% of participants reporting adequate adherence. Higher resilience scores were associated with lower odds of depression (adjusted [aOR] = 0.958, 95% CI: 0.939–0.977), anxiety (aOR = 0.971, 95% CI: 0.950–0.993, p = 0.010) and an increased odds of at least 95% antiretroviral therapy adherence (aOR = 1.033, 95% CI: 1.008–1.058, p = 0.009). In this study of older adults living with HIV in Nigeria, the level of resilience was low but was protective for psychiatric morbidity and medication adherence. Promoting resilience may improve well-being among aging populations living with HIV.
- 8 October 2026
- Published by Springer Nature in Research Square
Open AccessThe Association of Resilience with Psychiatric Morbidity, Sleep Quality and Antiretroviral Therapy Adherence among Older Adults Living with HIV in Nigeria
Advances in antiretroviral therapy (ART) have increased survival among people living with HIV, resulting in a growing population of older adults who often face persistent psychological challenges. However, limited evidence exists on how in the face of these challenges, resilience may interact with psychiatric morbidity and HIV treatment adherence in African countries. This study therefore examined resilience among older adults living with HIV in Ibadan, Nigeria and its association with psychiatric morbidity and ART adherence. In this cross-sectional study, resilience, psychiatric morbidity and HIV treatment adherence were assessed among 400 older adults aged ≥ 50 years living with HIV. Resilience, depression, anxiety and sleep quality were measured using the 25-item Wagnild and Young resilience scale, Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder 7-item scale (GAD-7) and the Pittsburgh Sleep Quality Index (PSQI) respectively. Antiretroviral medication adherence was self-reported for the prior 30-days. Associations between resilience levels, psychiatric morbidity, and medication adherence outcomes were investigated using multivariable logistic regression controlling for demographic and clinical factors. The mean age of participants was 58.2 ± 6.5 years. Low resilience was common, affecting approximately 89.7% of the cohort. The prevalence of psychiatric morbidity was 7.8% for depression, 6.0% for anxiety, and 15.2% for poor sleep quality. Overall, ART adherence was relatively high, with 85.5% of participants reporting adequate adherence. Higher resilience scores were associated with lower odds of depression (adjusted [aOR] = 0.958, 95% CI: 0.939–0.977), anxiety (aOR = 0.971, 95% CI: 0.950–0.993, p = 0.010) and an increased odds of at least 95% antiretroviral therapy adherence (aOR = 1.033, 95% CI: 1.008–1.058, p = 0.009). In this study of older adults living with HIV in Nigeria, the level of resilience was low but was protective for psychiatric morbidity and medication adherence. Promoting resilience may improve well-being among aging populations living with HIV.
- Open Access
- 3 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e74199
A Mobile Game Intervention for Young Persons Living With HIV and Depression in Nigeria: Protocol for a Pilot Randomized Controlled Trial
Background: Young people living with HIV bear a disproportionate burden of depression, which is associated with poor HIV outcomes. Problem-solving therapy (PST) has been shown to be effective for depression management and can be delivered with fidelity by nonspecialists, especially in resource-limited settings. PST is designed to equip individuals to manage the impact of stressful life events on their mental health. Change My Story is a narrative digital game designed to improve PST engagement among young people living with HIV in Nigeria. Objective: This trial will evaluate the impact of PST alone or PST with Change My Story on mental health outcomes among young people living with HIV in Nigeria. Methods: We will conduct a pilot hybrid implementation-effectiveness randomized controlled trial with 80 young people living with HIV (aged 16-24 years) in Nigeria with depression (9-item Patient Health Questionnaire [PHQ-9] ≥9) over 3 months. Participants will be randomized to receive PST with or without Change My Story. All participants will engage in weekly PST sessions for 6 weeks delivered by trained nonspecialists (clinic HIV adherence counselors). At 6 and 10-12 weeks, scores on PHQ-9 will determine the frequency of PST sessions during the remaining intervention period. Primary implementation outcomes, including engagement, satisfaction, feasibility, acceptability, and appropriateness from the participant perspective, will be assessed using validated scales, programmatic data, and focus group discussions at 3 months. Secondary clinical outcomes will assess changes in depressive symptoms, psychological distress, functional disability, antiretroviral therapy adherence, and HIV viral suppression at 3 and 6 months. Implementation outcomes (all but engagement and satisfaction) will be assessed through validated scales and focus group discussions from the implementer perspective at baseline and 6 months. Results: This study is funded by the US National Institutes of Health (funding commenced on March 8, 2024), institutional review board approval was received on April 15, 2024, and recruitment and data collection began in June 2025. Thus far, we have screened 103 youths and enrolled 23 participants. Among enrolled participants, 15 (65%) were male; 1 (4%) had a PHQ-9 score ≥17, and 6 (26%) had suicidal thoughts. We anticipate recruitment will be completed by January 2026 and follow-up by June 2026. We will assess our hypotheses that PST with Change My Story is feasible, acceptable, and appropriate and that individuals receiving PST integrated with Change My Story will have greater engagement, satisfaction, and depression remission compared to those receiving PST alone. Conclusions: This pilot randomized controlled trial attempts to establish preliminary data on the feasibility, acceptability, appropriateness, and efficacy of task-shifted PST and supplementary mobile health technology on improving HIV and mental health outcomes among young people living with HIV in Nigeria. These findings may serve as a basis for future large-scale interventions. Trial Registration: ClinicalTrials.gov NCT06389565; https://clinicaltrials.gov/study/NCT06389565 International Registered Report Identifier (IRRID): PRR1-10.2196/74199
- 3 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e74199
Open AccessA Mobile Game Intervention for Young Persons Living With HIV and Depression in Nigeria: Protocol for a Pilot Randomized Controlled Trial
Background: Young people living with HIV bear a disproportionate burden of depression, which is associated with poor HIV outcomes. Problem-solving therapy (PST) has been shown to be effective for depression management and can be delivered with fidelity by nonspecialists, especially in resource-limited settings. PST is designed to equip individuals to manage the impact of stressful life events on their mental health. Change My Story is a narrative digital game designed to improve PST engagement among young people living with HIV in Nigeria. Objective: This trial will evaluate the impact of PST alone or PST with Change My Story on mental health outcomes among young people living with HIV in Nigeria. Methods: We will conduct a pilot hybrid implementation-effectiveness randomized controlled trial with 80 young people living with HIV (aged 16-24 years) in Nigeria with depression (9-item Patient Health Questionnaire [PHQ-9] ≥9) over 3 months. Participants will be randomized to receive PST with or without Change My Story. All participants will engage in weekly PST sessions for 6 weeks delivered by trained nonspecialists (clinic HIV adherence counselors). At 6 and 10-12 weeks, scores on PHQ-9 will determine the frequency of PST sessions during the remaining intervention period. Primary implementation outcomes, including engagement, satisfaction, feasibility, acceptability, and appropriateness from the participant perspective, will be assessed using validated scales, programmatic data, and focus group discussions at 3 months. Secondary clinical outcomes will assess changes in depressive symptoms, psychological distress, functional disability, antiretroviral therapy adherence, and HIV viral suppression at 3 and 6 months. Implementation outcomes (all but engagement and satisfaction) will be assessed through validated scales and focus group discussions from the implementer perspective at baseline and 6 months. Results: This study is funded by the US National Institutes of Health (funding commenced on March 8, 2024), institutional review board approval was received on April 15, 2024, and recruitment and data collection began in June 2025. Thus far, we have screened 103 youths and enrolled 23 participants. Among enrolled participants, 15 (65%) were male; 1 (4%) had a PHQ-9 score ≥17, and 6 (26%) had suicidal thoughts. We anticipate recruitment will be completed by January 2026 and follow-up by June 2026. We will assess our hypotheses that PST with Change My Story is feasible, acceptable, and appropriate and that individuals receiving PST integrated with Change My Story will have greater engagement, satisfaction, and depression remission compared to those receiving PST alone. Conclusions: This pilot randomized controlled trial attempts to establish preliminary data on the feasibility, acceptability, appropriateness, and efficacy of task-shifted PST and supplementary mobile health technology on improving HIV and mental health outcomes among young people living with HIV in Nigeria. These findings may serve as a basis for future large-scale interventions. Trial Registration: ClinicalTrials.gov NCT06389565; https://clinicaltrials.gov/study/NCT06389565 International Registered Report Identifier (IRRID): PRR1-10.2196/74199
- Open Access
- 20 March 2025
- Published by JMIR Publications Inc. in JMIR Preprints
A Mobile Game Intervention for Young Persons Living With HIV and Depression in Nigeria: Protocol for a Pilot Randomized Controlled Trial (Preprint)
BACKGROUND Young people living with HIV bear a disproportionate burden of depression, which is associated with poor HIV outcomes. Problem-solving therapy (PST) has been shown to be effective for depression management and can be delivered with fidelity by nonspecialists, especially in resource-limited settings. PST is designed to equip individuals to manage the impact of stressful life events on their mental health. Change My Story is a narrative digital game designed to improve PST engagement among young people living with HIV in Nigeria. OBJECTIVE This trial will evaluate the impact of PST alone or PST with Change My Story on mental health outcomes among young people living with HIV in Nigeria. METHODS We will conduct a pilot hybrid implementation-effectiveness randomized controlled trial with 80 young people living with HIV (aged 16-24 years) in Nigeria with depression (9-item Patient Health Questionnaire [PHQ-9] ≥9) over 3 months. Participants will be randomized to receive PST with or without Change My Story. All participants will engage in weekly PST sessions for 6 weeks delivered by trained nonspecialists (clinic HIV adherence counselors). At 6 and 10-12 weeks, scores on PHQ-9 will determine the frequency of PST sessions during the remaining intervention period. Primary implementation outcomes, including engagement, satisfaction, feasibility, acceptability, and appropriateness from the participant perspective, will be assessed using validated scales, programmatic data, and focus group discussions at 3 months. Secondary clinical outcomes will assess changes in depressive symptoms, psychological distress, functional disability, antiretroviral therapy adherence, and HIV viral suppression at 3 and 6 months. Implementation outcomes (all but engagement and satisfaction) will be assessed through validated scales and focus group discussions from the implementer perspective at baseline and 6 months. RESULTS This study is funded by the US National Institutes of Health (funding commenced on March 8, 2024), institutional review board approval was received on April 15, 2024, and recruitment and data collection began in June 2025. Thus far, we have screened 103 youths and enrolled 23 participants. Among enrolled participants, 15 (65%) were male; 1 (4%) had a PHQ-9 score ≥17, and 6 (26%) had suicidal thoughts. We anticipate recruitment will be completed by January 2026 and follow-up by June 2026. We will assess our hypotheses that PST with Change My Story is feasible, acceptable, and appropriate and that individuals receiving PST integrated with Change My Story will have greater engagement, satisfaction, and depression remission compared to those receiving PST alone. CONCLUSIONS This pilot randomized controlled trial attempts to establish preliminary data on the feasibility, acceptability, appropriateness, and efficacy of task-shifted PST and supplementary mobile health technology on improving HIV and mental health outcomes among young people living with HIV in Nigeria. These findings may serve as a basis for future large-scale interventions. CLINICALTRIAL ClinicalTrials.gov NCT06389565; https://clinicaltrials.gov/study/NCT06389565 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/74199
- 20 March 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Mobile Game Intervention for Young Persons Living With HIV and Depression in Nigeria: Protocol for a Pilot Randomized Controlled Trial (Preprint)
BACKGROUND Young people living with HIV bear a disproportionate burden of depression, which is associated with poor HIV outcomes. Problem-solving therapy (PST) has been shown to be effective for depression management and can be delivered with fidelity by nonspecialists, especially in resource-limited settings. PST is designed to equip individuals to manage the impact of stressful life events on their mental health. Change My Story is a narrative digital game designed to improve PST engagement among young people living with HIV in Nigeria. OBJECTIVE This trial will evaluate the impact of PST alone or PST with Change My Story on mental health outcomes among young people living with HIV in Nigeria. METHODS We will conduct a pilot hybrid implementation-effectiveness randomized controlled trial with 80 young people living with HIV (aged 16-24 years) in Nigeria with depression (9-item Patient Health Questionnaire [PHQ-9] ≥9) over 3 months. Participants will be randomized to receive PST with or without Change My Story. All participants will engage in weekly PST sessions for 6 weeks delivered by trained nonspecialists (clinic HIV adherence counselors). At 6 and 10-12 weeks, scores on PHQ-9 will determine the frequency of PST sessions during the remaining intervention period. Primary implementation outcomes, including engagement, satisfaction, feasibility, acceptability, and appropriateness from the participant perspective, will be assessed using validated scales, programmatic data, and focus group discussions at 3 months. Secondary clinical outcomes will assess changes in depressive symptoms, psychological distress, functional disability, antiretroviral therapy adherence, and HIV viral suppression at 3 and 6 months. Implementation outcomes (all but engagement and satisfaction) will be assessed through validated scales and focus group discussions from the implementer perspective at baseline and 6 months. RESULTS This study is funded by the US National Institutes of Health (funding commenced on March 8, 2024), institutional review board approval was received on April 15, 2024, and recruitment and data collection began in June 2025. Thus far, we have screened 103 youths and enrolled 23 participants. Among enrolled participants, 15 (65%) were male; 1 (4%) had a PHQ-9 score ≥17, and 6 (26%) had suicidal thoughts. We anticipate recruitment will be completed by January 2026 and follow-up by June 2026. We will assess our hypotheses that PST with Change My Story is feasible, acceptable, and appropriate and that individuals receiving PST integrated with Change My Story will have greater engagement, satisfaction, and depression remission compared to those receiving PST alone. CONCLUSIONS This pilot randomized controlled trial attempts to establish preliminary data on the feasibility, acceptability, appropriateness, and efficacy of task-shifted PST and supplementary mobile health technology on improving HIV and mental health outcomes among young people living with HIV in Nigeria. These findings may serve as a basis for future large-scale interventions. CLINICALTRIAL ClinicalTrials.gov NCT06389565; https://clinicaltrials.gov/study/NCT06389565 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/74199
- Open Access
- 10 January 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e71141
Exploratory Impact of iCARE Nigeria, a combined mHealth and Peer Navigation Intervention, on Depressive Symptoms and Substance Use Among Youth Living With HIV In Nigeria: a single-arm trial (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Mental health problems are a barrier to the wellbeing of youth living with HIV (YLWH). Many YLWH in Nigeria face peculiar bio-psycho-social vulnerabilities that predispose them to mental health problems including depression and substance use. In addition to improving treatment outcomes like medication adherence and linkage to care, peer engagement has shown some promise in improving the social and emotional wellbeing of this population. Mobile health (mHealth) interventions like SMS medication reminders may also contribute to better outcomes in YLWH. Emerging evidence suggests that combination interventions may be more effective than single interventions in improving key HIV testing and treatment outcomes among youth in Nigeria. Objective: To explore the impact of Intensive Combination Approach to Rollback the Epidemic in Nigerian Adolescents (iCARE Nigeria) study— an mHealth+peer navigation intervention primarily aimed at medication adherence and viral suppression— on depressive symptoms and substance use among YLWH in Nigeria Methods: A single-arm clinical trial was conducted at the Infectious Disease Institute (IDI), College of Medicine, University of Ibadan, Nigeria— primarily to improve medication adherence and viral suppression among YLWH attending its HIV clinic. The intervention combined peer navigation and daily, two-way, text message medication reminders delivered over a period of 48 weeks. Participants were screened at baseline and follow-up visits (24 and 48 weeks) for depression and substance use using standardized measures. Paired t-tests and McNemar’s tests were used to investigate the change in depressive symptoms and the change in the proportion of participants reporting substance use over time, respectively. Results: All 40 enrolled participants (50% male; mean age 19.9, SD 2.5 years) completed baseline and follow-up visits at week 24, while 37 (92.5%) participants completed the week 48 visit. Compared with baseline, there were significantly fewer self-reported depressive symptoms observed at 48 weeks (M= 2.89 vs 2.08, t36=2.04, 95%CI=0.006-1.615) but not at 24 weeks (M= 2.28 vs 2.62, t36=0.47, 95%CI=-0.742-1.442). There were fewer self-reports of substance use at weeks 24 and 48 when compared to baseline, but these were not statistically significant (OR=∞, 95%CI= 0.189-∞ and OR= 3.0, 95%CI=0.241-157.492 respectively). Conclusions: These findings suggest a statistically significant reduction in depressive symptoms among YLWH over the 48-week intervention period that may be due to the iCARE Nigeria intervention. However, given limitations such as low levels of depressive symptoms at baseline, small sample size, and the lack of a control group, future studies such as the randomised stepped wedge evaluation of the iCARE intervention are needed to provide better insights into these exploratory findings.
- 10 January 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e71141
Open AccessExploratory Impact of iCARE Nigeria, a combined mHealth and Peer Navigation Intervention, on Depressive Symptoms and Substance Use Among Youth Living With HIV In Nigeria: a single-arm trial (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Mental health problems are a barrier to the wellbeing of youth living with HIV (YLWH). Many YLWH in Nigeria face peculiar bio-psycho-social vulnerabilities that predispose them to mental health problems including depression and substance use. In addition to improving treatment outcomes like medication adherence and linkage to care, peer engagement has shown some promise in improving the social and emotional wellbeing of this population. Mobile health (mHealth) interventions like SMS medication reminders may also contribute to better outcomes in YLWH. Emerging evidence suggests that combination interventions may be more effective than single interventions in improving key HIV testing and treatment outcomes among youth in Nigeria. Objective: To explore the impact of Intensive Combination Approach to Rollback the Epidemic in Nigerian Adolescents (iCARE Nigeria) study— an mHealth+peer navigation intervention primarily aimed at medication adherence and viral suppression— on depressive symptoms and substance use among YLWH in Nigeria Methods: A single-arm clinical trial was conducted at the Infectious Disease Institute (IDI), College of Medicine, University of Ibadan, Nigeria— primarily to improve medication adherence and viral suppression among YLWH attending its HIV clinic. The intervention combined peer navigation and daily, two-way, text message medication reminders delivered over a period of 48 weeks. Participants were screened at baseline and follow-up visits (24 and 48 weeks) for depression and substance use using standardized measures. Paired t-tests and McNemar’s tests were used to investigate the change in depressive symptoms and the change in the proportion of participants reporting substance use over time, respectively. Results: All 40 enrolled participants (50% male; mean age 19.9, SD 2.5 years) completed baseline and follow-up visits at week 24, while 37 (92.5%) participants completed the week 48 visit. Compared with baseline, there were significantly fewer self-reported depressive symptoms observed at 48 weeks (M= 2.89 vs 2.08, t36=2.04, 95%CI=0.006-1.615) but not at 24 weeks (M= 2.28 vs 2.62, t36=0.47, 95%CI=-0.742-1.442). There were fewer self-reports of substance use at weeks 24 and 48 when compared to baseline, but these were not statistically significant (OR=∞, 95%CI= 0.189-∞ and OR= 3.0, 95%CI=0.241-157.492 respectively). Conclusions: These findings suggest a statistically significant reduction in depressive symptoms among YLWH over the 48-week intervention period that may be due to the iCARE Nigeria intervention. However, given limitations such as low levels of depressive symptoms at baseline, small sample size, and the lack of a control group, future studies such as the randomised stepped wedge evaluation of the iCARE intervention are needed to provide better insights into these exploratory findings.
- 9 December 2024
- Published by Springer Nature in AIDS and Behavior
- Vol. 29 (3) , 848-857
Risk Factors for Viral Non-suppression Among Youth Living with HIV in Nigeria: Findings from the iCARE Nigeria Study
Viral suppression with antiretroviral therapy (ART) is a critical component of UNAIDS objectives to end the HIV epidemic. Youth living with HIV (YLH) have worse viral suppression rates than adults. The aim of this study was to identify risk factors for viral non-suppression among YLH in Nigeria. A secondary analysis of enrollment data from the iCARE Nigeria study, collected April–October 2021 for 541 YLH comprised demographic, psychosocial, behavioral, clinical variables, and viral load quantification. Viral non-suppression was defined as viral load ≥ 200 copies/mL. Generalized linear models using Akaike information criterion for selection of indicator variables in a stepwise approach were used to determine the risk factors for viral non-suppression. The final analytic sample was 491 and the proportion of non-suppressed participants at baseline was 40%. In the final model, substance use (other than alcohol, tobacco and/or cannabis) (aOR = 3.20 [95% CI: 1.05, 10.34]), missed medication doses (aOR = 1.09 [95% CI: 1.04, 1.15]), and a higher number of self-reported medication barriers (e.g., forgot, busy, change in routine) (aOR = 1.08 [95% CI: 1.00, 1.16]) were associated with a higher likelihood of viral non-suppression. Being prescribed a first-line regimen (aOR = 0.28 [95% CI: 0.17, 0.44]), disclosure to at least one brother (aOR = 0.64 [95% CI: 0.42, 0.97]), and higher treatment outcome expectancies (e.g., taking medication will improve health) (aOR = 0.81 [95% CI: 0.66, 0.98]), were all associated with a lower likelihood of viral non-suppression. Viral non-suppression among YLH in Nigeria is associated with psychosocial and behavioral factors, including missed doses, medication barriers, treatment outcome expectancies, and disclosure, that are potential targets for intervention to achieve ART goals.
- 9 December 2024
- Published by Springer Nature in AIDS and Behavior
- Vol. 29 (3) , 848-857
Risk Factors for Viral Non-suppression Among Youth Living with HIV in Nigeria: Findings from the iCARE Nigeria Study
Viral suppression with antiretroviral therapy (ART) is a critical component of UNAIDS objectives to end the HIV epidemic. Youth living with HIV (YLH) have worse viral suppression rates than adults. The aim of this study was to identify risk factors for viral non-suppression among YLH in Nigeria. A secondary analysis of enrollment data from the iCARE Nigeria study, collected April–October 2021 for 541 YLH comprised demographic, psychosocial, behavioral, clinical variables, and viral load quantification. Viral non-suppression was defined as viral load ≥ 200 copies/mL. Generalized linear models using Akaike information criterion for selection of indicator variables in a stepwise approach were used to determine the risk factors for viral non-suppression. The final analytic sample was 491 and the proportion of non-suppressed participants at baseline was 40%. In the final model, substance use (other than alcohol, tobacco and/or cannabis) (aOR = 3.20 [95% CI: 1.05, 10.34]), missed medication doses (aOR = 1.09 [95% CI: 1.04, 1.15]), and a higher number of self-reported medication barriers (e.g., forgot, busy, change in routine) (aOR = 1.08 [95% CI: 1.00, 1.16]) were associated with a higher likelihood of viral non-suppression. Being prescribed a first-line regimen (aOR = 0.28 [95% CI: 0.17, 0.44]), disclosure to at least one brother (aOR = 0.64 [95% CI: 0.42, 0.97]), and higher treatment outcome expectancies (e.g., taking medication will improve health) (aOR = 0.81 [95% CI: 0.66, 0.98]), were all associated with a lower likelihood of viral non-suppression. Viral non-suppression among YLH in Nigeria is associated with psychosocial and behavioral factors, including missed doses, medication barriers, treatment outcome expectancies, and disclosure, that are potential targets for intervention to achieve ART goals.
- Open Access
- 1 February 2023
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 9 (9) , e2100140
Cancer Genetic Services in a Low- to Middle-Income Country: Cross-Sectional Survey Assessing Willingness to Undergo and Pay for Germline Genetic Testing
PURPOSE: Cancer genetic testing (CGT), a pathway to personalized medicine, is also being embraced in Nigeria. However, little is known about the influence of demographics and perceptions on individuals' willingness to access and pay for CGT. This study assessed patients' willingness to undergo CGT in southwest Nigeria as a catalyst for sustainable Cancer Risk Management Program. METHODS: This was a cross-sectional study using semistructured questionnaire to interview 362 patients with cancer and 10 referred first-degree relatives between July 2018 and February 2020. Participants from three Nigerian teaching hospitals—University College Hospital, Ibadan, Lagos State University Teaching Hospital, Lagos, and Lagos University Teaching Hospital, Lagos, received genetic counseling and had subsequent CGT. Primary outcomes were willingness to undergo CGT in determining cancer risk and the willingness to pay for it. Ethical approval was from appropriate ethics committees of participating hospitals. Data were analyzed with SPSS version 22. Univariate comparison of categorical variables was performed by χ2 test, multivariate analysis by logistic regression. RESULTS: The participants from University College Hospital (56.2%), Lagos State University Teaching Hospital (26.3%), and Lagos University Teaching Hospital (17.5%) were mostly female (98.4%). Mean age was 48.8 years ± 11.79. Three hundred twenty-two (86.6%) patients and first-degree relatives were willing to take the test, of whom 231 (71.1%) were willing to pay for it. more than half (53.6%) of the participants were willing to pay between N10,000 and N30,000, which is less than $100 US dollars. Sociodemographic variables and willingness to test showed no association ( P > .05). Education and ethnicity were found to be associated with their willingness to pay for CGT ( P ≤ .05). CONCLUSION: Learning clinically relevant details toward cancer prevention informs health-related decisions in patients and relatives, a motivator for willingness to pay for genetic testing in low- and middle-income countries. Increased awareness may influence outcomes of cancer risk management.
- 1 February 2023
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 9 (9) , e2100140
Open AccessCancer Genetic Services in a Low- to Middle-Income Country: Cross-Sectional Survey Assessing Willingness to Undergo and Pay for Germline Genetic Testing
PURPOSE: Cancer genetic testing (CGT), a pathway to personalized medicine, is also being embraced in Nigeria. However, little is known about the influence of demographics and perceptions on individuals' willingness to access and pay for CGT. This study assessed patients' willingness to undergo CGT in southwest Nigeria as a catalyst for sustainable Cancer Risk Management Program. METHODS: This was a cross-sectional study using semistructured questionnaire to interview 362 patients with cancer and 10 referred first-degree relatives between July 2018 and February 2020. Participants from three Nigerian teaching hospitals—University College Hospital, Ibadan, Lagos State University Teaching Hospital, Lagos, and Lagos University Teaching Hospital, Lagos, received genetic counseling and had subsequent CGT. Primary outcomes were willingness to undergo CGT in determining cancer risk and the willingness to pay for it. Ethical approval was from appropriate ethics committees of participating hospitals. Data were analyzed with SPSS version 22. Univariate comparison of categorical variables was performed by χ2 test, multivariate analysis by logistic regression. RESULTS: The participants from University College Hospital (56.2%), Lagos State University Teaching Hospital (26.3%), and Lagos University Teaching Hospital (17.5%) were mostly female (98.4%). Mean age was 48.8 years ± 11.79. Three hundred twenty-two (86.6%) patients and first-degree relatives were willing to take the test, of whom 231 (71.1%) were willing to pay for it. more than half (53.6%) of the participants were willing to pay between N10,000 and N30,000, which is less than $100 US dollars. Sociodemographic variables and willingness to test showed no association ( P > .05). Education and ethnicity were found to be associated with their willingness to pay for CGT ( P ≤ .05). CONCLUSION: Learning clinically relevant details toward cancer prevention informs health-related decisions in patients and relatives, a motivator for willingness to pay for genetic testing in low- and middle-income countries. Increased awareness may influence outcomes of cancer risk management.
- Open Access
- 4 October 2022
- Published by Springer Nature in Research Square
Prevalence and Factors Associated with Genital Tobacco Powder Use Among Women in Gambia: A Mixed Study
Background Genital tobacco powder, locally known as "tabaa," is a mixture of powdered tobacco and other substances that women use vaginally for sexual enhancement. Through a media report, the Ministry of Health issued a warning for women to stop the practice. However, literature search showed that no any scientific study documenting the burden of this cultural practice beyond media reports. The aim of this study was to determine the prevalence and factors associated with genital tobacco powder use among women in The Gambia. Methods A sequential exploratory mixed approach was used. The research was carried out in two areas of The Gambia: one rural (Farafenni) and one urban (Banjul). Focus group discussions and in-depth interviews were used to recruit (30) participants in the qualitative study. The quantitative study interviewed (400) women using structured questionnaire that was developed from the qualitative results. SPSS version 24 and STATA version 7 were used to analyze the data. Descriptive, Bivariate and multivariate statistics were used to summarize the data. Results Most of the study participants were between 30–39 years old who were married. The prevalence (17.0%; n = 68) of genital tobacco powder was high among women aged 40 years and above (OR = 2.88; 95% CI = 1.03–8.05; p = 0.04), from Farafenni and satellite villages (OR = 2.01; 95% CI = 1.02–3.96; p = 0.04), had non-formal education (OR = 3.09; 95% CI 0.85–11.26; p = 0.02) and had husbands who traveled for 6 (OR = 6.67; 95% CI = 1.71–26.01; p = 0.006) or 12 or more months (OR = 9.64; 95% CI 3.19–29.18; p < 0.001). The perception of women and peer influence were associated with genital tobacco powder use. Conclusion Genital tobacco powder is practiced all over the Gambia and highest in the rural areas. Socio-demographic variables such age, residence, marital status, education status were significantly associated with the practice. According to the findings, women with low level of education and have poor perception can easily be convinced by close friends/family members to use genital tobacco powder. Therefore, awareness creation is the most important intervention to mitigate this practice.
- 4 October 2022
- Published by Springer Nature in Research Square
Open AccessPrevalence and Factors Associated with Genital Tobacco Powder Use Among Women in Gambia: A Mixed Study
Background Genital tobacco powder, locally known as "tabaa," is a mixture of powdered tobacco and other substances that women use vaginally for sexual enhancement. Through a media report, the Ministry of Health issued a warning for women to stop the practice. However, literature search showed that no any scientific study documenting the burden of this cultural practice beyond media reports. The aim of this study was to determine the prevalence and factors associated with genital tobacco powder use among women in The Gambia. Methods A sequential exploratory mixed approach was used. The research was carried out in two areas of The Gambia: one rural (Farafenni) and one urban (Banjul). Focus group discussions and in-depth interviews were used to recruit (30) participants in the qualitative study. The quantitative study interviewed (400) women using structured questionnaire that was developed from the qualitative results. SPSS version 24 and STATA version 7 were used to analyze the data. Descriptive, Bivariate and multivariate statistics were used to summarize the data. Results Most of the study participants were between 30–39 years old who were married. The prevalence (17.0%; n = 68) of genital tobacco powder was high among women aged 40 years and above (OR = 2.88; 95% CI = 1.03–8.05; p = 0.04), from Farafenni and satellite villages (OR = 2.01; 95% CI = 1.02–3.96; p = 0.04), had non-formal education (OR = 3.09; 95% CI 0.85–11.26; p = 0.02) and had husbands who traveled for 6 (OR = 6.67; 95% CI = 1.71–26.01; p = 0.006) or 12 or more months (OR = 9.64; 95% CI 3.19–29.18; p < 0.001). The perception of women and peer influence were associated with genital tobacco powder use. Conclusion Genital tobacco powder is practiced all over the Gambia and highest in the rural areas. Socio-demographic variables such age, residence, marital status, education status were significantly associated with the practice. According to the findings, women with low level of education and have poor perception can easily be convinced by close friends/family members to use genital tobacco powder. Therefore, awareness creation is the most important intervention to mitigate this practice.
- Open Access
- 13 July 2022
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 789
Case Report: Incidental finding of didelphys uterus in a multigravida woman at Caesarean delivery
Didelphys uterus is one of the rarest Müllerian duct anomalies (MDA) of the female genital tract. Many remain undiagnosed due to possibilities of successful pregnancies and vaginal deliveries in those without or with mild forms of associated cervical and/or vaginal anomalies. Due to this, data on didelphys uterus in pregnancy are rare, with most cases seen during routine ultrasound in pregnancies’ Caesarean section for other obstetric indications. This case was a 36-year-old G4P1+2 female who had successful vaginal delivery in her preceding pregnancy; in index pregnancy, she presented with fetal footling breech in labour and had an emergency caesarean section during which uterine didelphys was diagnosed. Many pregnant women with didelphys uterus will deliver vaginally and, as such, remain undiagnosed. Its presence is one of the possible reasons for persistent abnormal presentations like fetal breech presentation, especially in women with prior successful vaginal deliveries. Early recognition and availability of facilities for management of such incidentally found cases of uterine didelphys will prevent many of the complications associated with pregnancy with them.
- 13 July 2022
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 789
Open AccessCase Report: Incidental finding of didelphys uterus in a multigravida woman at Caesarean delivery
Didelphys uterus is one of the rarest Müllerian duct anomalies (MDA) of the female genital tract. Many remain undiagnosed due to possibilities of successful pregnancies and vaginal deliveries in those without or with mild forms of associated cervical and/or vaginal anomalies. Due to this, data on didelphys uterus in pregnancy are rare, with most cases seen during routine ultrasound in pregnancies’ Caesarean section for other obstetric indications. This case was a 36-year-old G4P1+2 female who had successful vaginal delivery in her preceding pregnancy; in index pregnancy, she presented with fetal footling breech in labour and had an emergency caesarean section during which uterine didelphys was diagnosed. Many pregnant women with didelphys uterus will deliver vaginally and, as such, remain undiagnosed. Its presence is one of the possible reasons for persistent abnormal presentations like fetal breech presentation, especially in women with prior successful vaginal deliveries. Early recognition and availability of facilities for management of such incidentally found cases of uterine didelphys will prevent many of the complications associated with pregnancy with them.
- Open Access
- 20 May 2022
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 8 (8) , e2200017
Oncology Training Needs Assessment Among Health Care Professionals in Nigeria
PURPOSE: This study investigated the status of training and preparedness for oncology practice and research and degree of interprofessional collaboration among health care professionals in the six geopolitical regions of Nigeria. METHODS: A convergent parallel mixed methods design was used. Three hundred seventeen respondents completed a three-part, online questionnaire. Self-rated competencies in oncology research (26 items), oncology practice (16 items), and interprofessional collaboration (nine items) were assessed with a one- to five-point Likert scale. Six key informant and 24 in-depth interviews were conducted. Descriptive statistics, analysis of variance, and pairwise t-test were used to analyze the quantitative data, whereas thematic analysis was used for the qualitative data. RESULTS: Respondents were mostly female (65.6%) with a mean age of 40.5 ± 8.3 years. Respondents include 178 nurses (56.2%), 93 medical doctors (29.3%), and 46 pharmacists (14.5%). Self-assessed competencies in oncology practice differed significantly across the three groups of health care professionals ( F = 4.789, P = .009). However, there was no significant difference across professions for competency in oncology research ( F = 1.256, P = .286) and interprofessional collaboration ( F = 1.120, P = .327). The majority of respondents (267, 82.4%) felt that educational opportunities in oncology-associated research in the country are inadequate and that this has implications for practice. Key training gaps reported include poor preparedness in data analysis and bioinformatics (138, 43.5%), writing clinical trials (119, 37.5%), and writing grant/research proposals (105, 33.1%). Challenges contributing to gaps in cancer research include few trained oncology specialists, low funding for research, and inadequate interprofessional collaboration. CONCLUSION: This study highlights gaps in oncology training and practice and an urgent need for interventions to enhance interprofessional training to improve quality of cancer care in Nigeria. These would accelerate progress toward strengthening the health care system and reducing global disparities in cancer outcomes.
- 20 May 2022
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 8 (8) , e2200017
Open AccessOncology Training Needs Assessment Among Health Care Professionals in Nigeria
PURPOSE: This study investigated the status of training and preparedness for oncology practice and research and degree of interprofessional collaboration among health care professionals in the six geopolitical regions of Nigeria. METHODS: A convergent parallel mixed methods design was used. Three hundred seventeen respondents completed a three-part, online questionnaire. Self-rated competencies in oncology research (26 items), oncology practice (16 items), and interprofessional collaboration (nine items) were assessed with a one- to five-point Likert scale. Six key informant and 24 in-depth interviews were conducted. Descriptive statistics, analysis of variance, and pairwise t-test were used to analyze the quantitative data, whereas thematic analysis was used for the qualitative data. RESULTS: Respondents were mostly female (65.6%) with a mean age of 40.5 ± 8.3 years. Respondents include 178 nurses (56.2%), 93 medical doctors (29.3%), and 46 pharmacists (14.5%). Self-assessed competencies in oncology practice differed significantly across the three groups of health care professionals ( F = 4.789, P = .009). However, there was no significant difference across professions for competency in oncology research ( F = 1.256, P = .286) and interprofessional collaboration ( F = 1.120, P = .327). The majority of respondents (267, 82.4%) felt that educational opportunities in oncology-associated research in the country are inadequate and that this has implications for practice. Key training gaps reported include poor preparedness in data analysis and bioinformatics (138, 43.5%), writing clinical trials (119, 37.5%), and writing grant/research proposals (105, 33.1%). Challenges contributing to gaps in cancer research include few trained oncology specialists, low funding for research, and inadequate interprofessional collaboration. CONCLUSION: This study highlights gaps in oncology training and practice and an urgent need for interventions to enhance interprofessional training to improve quality of cancer care in Nigeria. These would accelerate progress toward strengthening the health care system and reducing global disparities in cancer outcomes.